Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11
Crossref DOI link: https://doi.org/10.1007/s13300-021-01140-9
Published Online: 2021-09-12
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Van, Joanna
Frias, Juan P.
Bonora, Enzo
Raha, Sohini
Meyer, Jarrett
Jung, Heike
Cox, David
Konig, Manige
Peleshok, Jennifer
Bethel, M. Angelyn
Text and Data Mining valid from 2021-09-12
Version of Record valid from 2021-09-12
Article History
Received: 2 July 2021
Accepted: 6 August 2021
First Online: 12 September 2021